✨ Education and Health Notices
NEW ZEALAND GAZETTE, No. 140 — 20 NOVEMBER 2014
The guidelines are available, free of charge, from the Local Government Commission, PO Box 5362, Wellington, or may be downloaded from the Commission’s website
or may be inspected at the Commission’s offices at Level 10, 46 Waring Taylor Street, Wellington.
DONALD RIEZEBOS, Principal Advisor, Local Government Commission.
2014-go7073
Notice of Dissolution of Isla Bank School (3969) Board of Trustees and Appointment of a Commissioner
Pursuant to section 78N(3)(b) of the Education Act 1989, as the Secretary for Education’s delegate, I hereby dissolve the board of trustees of Isla Bank School and appoint
Paul Ferris
as commissioner to replace that board.
This notice takes effect on the day of publication.
Dated at Wellington this 12th day of November 2014.
JIM GREENING, Group Manager, Schools and Student Support, Sector Enablement and Support, Ministry of Education.
2014-go7008
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Aciclovir-Claris
Active Ingredient:
Aciclovir 25mg/mL
Dosage Form:
Solution for infusion
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Claris Life Sciences Limited, Gujarat, India
Product:
Cefuroxime Actavis
Active Ingredient:
Cefuroxime sodium 789mg equivalent to Cefuroxime 750mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Actavis New Zealand Limited
Manufacturer:
Facta Farmaceutica SpA, Teramo, Italy
Product:
Cefuroxime Actavis
Active Ingredient:
Cefuroxime sodium 1578mg equivalent to Cefuroxime 1500mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Actavis New Zealand Limited
Manufacturer:
Facta Farmaceutica SpA, Teramo, Italy
Product:
Clonidine Transdermal System, USP
Active Ingredient:
Clonidine 2.52mg equivalent to 0.1mg/24hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Technologies, Vermont, United States of America
Product:
Clonidine Transdermal System, USP
Active Ingredient:
Clonidine 5.04mg equivalent to 0.2mg/24hr
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Technologies, Vermont, United States of America
144
Next Page →
✨ LLM interpretation of page content
🏘️ Guidelines for Local Authority Representation Reviews
🏘️ Provincial & Local GovernmentLocal Government Commission, Representation Reviews, Guidelines
- Donald Riezebos, Principal Advisor, Local Government Commission
🎓 Dissolution of Isla Bank School Board of Trustees and Appointment of Commissioner
🎓 Education, Culture & Science12 November 2014
School Board, Dissolution, Commissioner Appointment, Isla Bank School
- Paul Ferris, Appointed Commissioner
- Jim Greening, Group Manager, Schools and Student Support, Sector Enablement and Support, Ministry of Education
🏥 Consent to Distribution of New Medicines
🏥 Health & Social WelfareMedicines, Consent, Distribution, Medicines Act 1981
- Minister of Health
NZ Gazette 2014, No 140